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RACIAL/ETHNIC DISPARITIES IN IN NUTRITIONAL DEFICIENCIES 
RELATED TO ANEMIA AFTER BARIATRIC SURGERY  
SHELBY BURNS 
 
ABSTRACT 
Background:  Bariatric surgery is effective for weight loss, but is associated with 
deficiencies of several micronutrients. Among these, deficiencies in iron and vitamin B12 
have been well-described in the literature. While it is known that blood levels of several 
micronutrients differ between racial groups, it is currently unknown whether the impact 
of bariatric surgery on micronutrient levels is also race-specific. We addressed this 
question in reference to vitamin B12 and iron because of the known racial differences in 
these micronutrients and their impact on red blood cell indices.  
The aim of our study was to determine whether there are differences in levels of ferritin 
and vitamin B12, as well as in hemoglobin (HGB) and hematocrit (HCT) levels, between 
African-Americans (AA), Hispanic-Americans (HA), and Caucasian-Americans (CA) 
after Roux-en-Y gastric bypass (RYGB) surgery.  
Methods: A retrospective medical record review of 1,046 (201 AA, 106 HA, and 344 
CA), who underwent bariatric surgery at Boston Medical Center (BMC) between 2004 
and 2015 was conducted. Analysis of variance and linear mixed modeling was used to 
compare adjusted mean changes in biomarkers of anemia, vitamin B12, and ferritin  
between racial groups before RYGB and up to a period of 4+ years after the surgery.  
Results: There were significant decreases in all racial/ethnic groups in mean HCT and 
HGB within the first year following surgery. Mean HCT from baseline to time point 1 
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(6months-1 year post-operatively) decreased by 3.3% for AA’s (p<0.001), 3.2% for HA’s 
(p<0.001), and 5% (p<0.001) for CA’s.  Mean HCT and mean HGB for the entire sample 
decreased from baseline to the end of the observation period by 4.4% and 1.45 g/L, 
respectively. AA's had lower levels of HCT and HGB throughout the observation period 
compared to HA's and CA's in both the unadjusted and adjusted models. CA's had the 
highest levels of these blood markers. Decreases in ferritin were also significant, with a 
decrease from baseline to the end of the observation period of 27.8 μg/L for AA's 
(p=0.004), a decrease of 49.6 μg/L for HA's (p<0.001), and 54.5 μg/L (p<0.001) for 
CA's. In comparison with HA's and AA's, CA's had a higher ferritin level at baseline 
(p=0.715 and p=0.028, respectively). However, when adjusted for age, sex, and initial 
BMI, CA's had lower ferritin levels throughout much of the observation period compared 
to HA's and AA's. After an initial increase at 6 months- 1 year post-operatively (time 
point 1), mean B12 levels remained fairly stable throughout the observation period with 
levels only slightly declining for AA’s and HA’s over the observation period. Levels 
remained higher than baseline for all racial/ethnic groups with mean B12 levels at the end 
increasing by 144.6 ng/L for AA’s (p<0.001), 70.4 ng/L for HA’s (p=0.186), and 182.2 
ng/L for CA’s (p<0.001). Though CA’s saw the greatest increase in mean B12 levels 
from baseline, AA’s had the highest mean B12 levels over the entire observation period, 
with significantly different levels compared to HA’s and CA’s at time points 1 (p=0.003 
and p=0.028, respectively) and 3 (p=0.050 and p=0.042, respectively). Additionally, 
when other factors significantly affecting mean HCT, HGB, ferritin, and B12 were 
analyzed and adjusted for in the mixed model, AA’s continued to have the lowest HCT 
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and HGB levels throughout much of the observation period, with CA's having the highest 
mean levels. For mean B12, even after adjusting for pre-BMI and sex, levels remained 
highest in AA’s compared to HA’ and CA’s.  
Conclusions: Our data demonstrate that ferritin levels, as well as red blood cell indices, 
decrease after RYGB and blood markers of anemia occur despite supplementation and 
post-operative follow-up care. We also show that ethnic minorities exhibit more 
exaggerated decreases in HCT and HGB, suggesting greater risk of anemia after RYGB 
in these groups. Thus, it is critical to consider race/ethnicity when providing treatment for 
patients undergoing gastric bypass surgery. However, future prospective studies are 
needed to further the preliminary results of this study.  
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INTRODUCTION 
 
Obesity is a global pandemic that is growing in prevalence and severity, and is 
often associated with comorbid conditions such as cardiovascular disease, type 2 
diabetes, dyslipidemia, sleep apnea, and degenerative osteoarthritis. While diet, exercise, 
and pharmacologic agents are commonly used in the treatment of patients with obesity, 
surgical weight loss is becoming an increasingly popular and effective intervention 
option1. In 2011, 340, 768 bariatric surgeries were performed worldwide3 compared with 
220,000 three years earlier in 2008.2 Roux-en-Y gastric bypass (RYBG) is the most 
commonly performed bariatric surgery, although there are several surgical alternatives.3 
While successful in producing desired weight loss and resolving or improving 
comorbidities, bariatric surgery is not without adverse side effects. Due to changes in the 
gastrointestinal anatomy and physiology, these surgeries have been shown to result in 
several nutritional deficiencies, most commonly B12, folate, vitamin D, and iron, despite 
oral supplementation.4,5,6  
 
Surgical Procedures for the Treatment of Obesity 
There are 3 major types of bariatric surgery: restrictive, malabsorptive, and a 
combination of the two. Restrictive procedures include the sleeve gastrectomy and the 
laparoscopic gastric band, restrictive-malabsorptive procedures include the Roux-en-Y 
gastric bypass (RYGB), and solely malabsorptive procedures include biliopancreatic 
diversion (BPD). RYGB is the most commonly performed bariatric procedure, followed 
by the sleeve gastrectomy (SG), and laparoscopic gastric band (lap-band).2  
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Restrictive procedures decrease the size of the stomach and mainly achieve 
weight loss through volume control by decreasing the amount of food that can be 
consumed. The malabsorptive procedures alter the anatomy of the GI tract by bypassing a 
portion of the small intestine, reducing the amount of surface area for nutrient utilization 
and absorption.4 It also has been suggested that these bariatric procedures work by 
altering our hormones involved in hunger, food intake, and satiety, such as decreasing our 
hormones that trigger feelings of hunger.7  
  Restrictive procedures, such as the lap-band and sleeve gastrectomy, often carry a 
lower risk of vitamin deficiencies as the anatomy of GI tract is altered the least. In the 
sleeve gastrectomy procedure, roughly 75% of the stomach is removed, resulting in a 
smaller stomach that takes the shape of a sleeve. For the lap-band procedure, an 
adjustable band is placed around the top part of the stomach, restricting the amount of 
food that the stomach can hold. In malabsorptive or combined procedures, such as the 
RYGB, an actual portion of the GI tract is bypassed and does not contribute to nutrient 
absorption and metabolism.  Figure 1 illustrates the sites along the GI tract where specific 
nutrients are mostly absorbed. Deficiencies of nutrients selectively absorbed in the 
duodenum are likely to occur because of the exclusion of absorptive sites.  Furthermore, 
the lack of stomach acid, alteration of the flow of food, and limited contact with 
pancreatic secretions, further predispose to incomplete digestion, reduced absorption, and 
increase in the incidence of micronutrient deficiencies.8,9  
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Figure 1. Sites of absorption of common vitamins and nutrients in the gastrointestinal tract. Taken from 
Bloomberg et al.4  
 
Dietary Recommendations Following Surgery: 
The nutritional needs of the patient will vary based on the nature of the operation, 
and clinical practice patterns of vitamin and mineral supplementation vary widely with 
different types of surgery. The American Association of Clinical Endocrinologist 
(AACE), the Obesity Society (TOS), and the American Society for Metabolic and 
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Bariatric Surgery (ASMBS) all recommend that patients should undergo appropriate 
nutritional evaluation, including selective micronutrient measurements before and after 
any bariatric surgical procedure.10 Routine supplementation with vitamins and minerals 
will likely be a lifelong requirement for many patients to help minimize the risk of 
nutritional deficiencies. After RYGB, supplementation with a multivitamin, iron, vitamin 
B12, and calcium with vitamin D is recommended; the specific dose of 350-600 
micrograms a day is recommended for vitamin B12 and at least 18 mg of iron.11 
However, patient compliance with nutritional supplements is often low, as is consistency 
with follow-up visits. Few studies have gained insights into patients’ adherence to 
supplement regimens and barriers to compliance.4, 12 Thus, behavioral factors, in addition 
to reduced absorption, further contribute to the development of multiple nutritional 
deficiencies after bariatric surgery.  
 
Nutritional Causes of Anemia 
Anemia is of interest in the bariatric population as it is one of the most common 
conditions that results from surgery.13, 5 Anemia is often defined by an insufficient 
number of RBCs and/or a decrease in the cells’ oxygen carrying capacity necessary to 
meet the body’s needs. There are several kinds of anemia, classified by RBC size and 
resulting from various causes. If the cells are smaller than normal, the anemia is called 
microcytic. If the cells are normal size, the anemia is normocytic, and if the cells are 
larger than normal, the anemia is classified as macrocytic. The size is reflected in the 
mean corpuscular volume (MCV), which is a measure of the average volume of red cells.  
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The most common type of anemia is iron deficiency anemia, which is often 
microcytic, and results from insufficient intake and/or absorption of iron.14 Normocytic 
anemia can be caused by acute blood loss or failure to produce enough RBCs. Macrocytic 
anemia most commonly results from a deficiency in vitamin B12 or folic acid due to 
inadequate intake or insufficient absorption.14   
Because of the restrictive and/or malabsorptive nature of bariatric surgery,   
iron deficiency anemia and vitamin B12 deficiency anemia are quite common post-
surgery.10,15,16 In a study by Weng et al., it was found that in RYGB patients, anemia 
increased from 12% pre-operatively to 26% at 24 months post-operatively, consistent 
with decreases in HGB and HCT.17 They found that ferritin deficiency increased from 8% 
to 23% and B12 deficiency increased from 2.3% to 6.5% from baseline to 24 months. It 
has also been found that the overall estimated incidence of anemia following RYGB 
surgery can range from 12% to 30%.18 
As iron stores are primarily controlled by absorption rather than excretion, iron 
deficiency is a regularly occurring nutritional deficiency following bariatric surgery.18,19,4 
It is especially common after RYGB, due to a reduction in gastric capacity as well as the 
bypassing of the duodenum and proximal jejunum, primary sites of iron absorption.6,15,16 
Iron is important for many cellular functions, including oxygen transport in 
RBCs. Therefore, low iron status frequently results in fatigue or shortness of breath. The 
adult body contains 3-4 g of iron, with the majority present in red blood cells and 
erythroid tissue. For example, hemoglobin, which is an iron-rich protein in the RBC, 
contains two-thirds of the total iron in the body.20 Though the typical Western diet 
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contains plenty of iron, only 1–2 mg is normally absorbed each day.14 The human diet 
contains two forms of iron: heme iron and nonheme iron. Heme iron is derived from meat 
and is well absorbed. Pancreatic enzymes then digest heme in the intestinal lumen. To be 
absorbed, dietary iron must be in heme protein form or in its ferrous, Fe2+ form. A 
duodenal ferric reductase enzyme aids in this reduction from ferric to ferrous iron prior to 
absorption.14,21 After absorption, iron is transported to the liver, where it may be stored in 
hepatocytes as ferritin or secreted on transferrin for distribution to body tissues. As 
ferritin is a blood cell protein that stores iron, it is a good indicator of iron stores and 
consequently, of iron deficiency. If iron is instead transported, the ferrous form is first 
oxidized back to Fe3 and then transported to the bone marrow and reticuloendothelial 
system for synthesis of hemoglobin in the mitochondria and incorporation into 
erythrocytes.22  
On the other hand, nonheme dietary iron, which is found in cereals, beans, and 
some vegetables, is less well absorbed. Nonheme iron is present as either ferric (Fe+3) or 
ferrous (Fe+2) iron.14 The acidic environment of the stomach and certain foods are 
important in reducing the ferric form to ferrous and thus increasing the bioavailability of 
dietary iron. Vitamin C, for example, helps to improve the absorption of iron. Therefore, 
when gastric acid is reduced or completely absent, iron absorption is decreased.23 
Because no regulatory physiologic mechanism for iron excretion exists, an 
average loss of 1–2 mg/d is necessary .14  On the other hand, the body can increase 
intestinal iron absorption depending on the body’s iron needs. When more iron is lost 
than is absorbed, iron stores become depleted and iron deficiency ensues. If the process 
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continues, iron deficiency anemia develops when iron stores are exhausted.  
 
Laboratory diagnosis of iron deficiency anemia 
The World Health Organization defines anemia as blood hemoglobin values of 
less than 13 g/dL in men and less than 12 g/dL in women, with the severity of anemia 
being based usually on the complete blood count of the patient’s hemoglobin, hematocrit, 
mean corpuscular volume, serum iron, transferrin saturation, total iron-binding capacity, 
and/or serum ferritin level. The ferritin level may be misleading, however, as it is an 
acute phase reactant and can be normal or even elevated in the presence of 
inflammation.24 Thus in the presence of an underlying infection or inflammation, other 
biomarkers of anemia such as HGB or HCT, should also be assessed.  
 
Folic and B12 Anemia 
The second major type of nutritional anemia is megaloblastic anemia, in which 
there is a defect in DNA synthesis, most often as a result of vitamin B12 and/or folic acid 
deficiency. The result is megaloblastic cells that grow larger, but do not divide, creating 
cell membranes that are weak and susceptible to lysis.  Because of their interrelated roles, 
a deficiency in either vitamin B12, folic acid, or a combination of the two will cause this 
type of anemia; thus, to differentiate the cause, both levels should be measured. 
Vitamin B12 works closely with folate to help make RBCs. Consequently, a 
deficiency in vitamin B12 can lead to a deficiency in folate due to what is known as the 
“methyl-trap of tetrahydrofolate” (THF).25 Methyl-THF is metabolized by methionine 
  
8
synthase, but methionine synthase activity is diminished with vitamin B12 deficiency, 
thus methyl-THF accumulates and has no way of being metabolized.25 Subsequently, a 
large pool of methyl-THF results that is unavailable to other tissues, consequently 
mimicking folate deficiency.25 Additionally, folate supplementation may mask vitamin 
B12 deficiency as folic acid can make the RBC, affected by vitamin B12 deficiency, 
appear normal; without folate, the vitamin B12 deficiency will result in megaloblastic, 
macrocytic anemia (large, structurally abnormal RBCs).26 The consequences of these 
deficiencies can include nerve damage, weakness, fatigue, paleness of the skin, and 
nausea.27  
Similar to iron deficiency, folic acid and vitamin B12 deficiencies develop as a 
result of  decreased absorption or inadequate intake through diet. Following bariatric 
surgery, macrocytic anemia is  attributed to decreased absorption resulting from the 
duodenum and upper jejunum being bypassed.10 Folic acid is most efficiently absorbed in 
the jejunum, whereas vitamin B12 is readily absorbed in the last part of the small 
intestine, the ileum.10 However, to be absorbed, vitamin B12 requires intrinsic factor (IF), 
which is produced in the stomach. Gastric surgery leads to a reduction in the amount of 
gastric acid, pepsin, and intrinsic factor produced, thereby reducing the amount of 
vitamin B12 available to be digested and absorbed.17,18 Thus, lack of IF post-operatively 
is the most common cause of vitamin B12 deficiency.28 It has been found that IF is no 
longer present in gastric juices beyond a bypassed gastric pouch, thus limiting the 
absorption ability of vitamin B12.29 Conversely, vitamin B12 deficiency is less common 
after purely restrictive surgeries as there is still access to gastric acid and IF.8 
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Vitamin B12 not only requires IF to be absorbed by the body, but it is also 
dependent on hydrochloric acid in the stomach.8 Hydrochloric acid, produced by the 
gastric parietal cells, aids in digestion in the stomach and helps to cleave vitamin B12 
bound to food, releasing it for absorption. However, when food no longer is entering the 
stomach or when food intake is minimal as is the case after bariatric surgery, 
hydrochloric acid production is reduced, consequently reducing absorption.30  
Unlike other water soluble vitamins, the body's reserves of vitamin B12 in the 
liver can normally sustain adequate levels over several years.28,8 Thus, daily oral 
supplementation of vitamin B12 (350–600 ug per day) has been shown to be effective in 
correcting deficiency in 81 to 95% of patients.11 
 
Copper Deficiency Anemia 
Though copper deficiency is rare in developed countries, bariatric surgery has 
been identified as a cause of copper deficiency anemia.31 Copper is an important cofactor 
for many enzymatic systems and plays an essential role in the normal functioning of 
vascular, skeletal, and neurological systems.31 However, because RYGB surgery 
bypasses the duodenum and proximal jejunum, the major sites of copper absorption, 
copper deficiency may manifest after this surgery.31 Copper deficiency is of interest 
because it can lead to significant cytopenias and possible neurological damage.31,32      
Furthermore, copper plays an important role in iron absorption and utilization, a 
mineral already malabsorbed after bariatric surgery.32 Depending upon its levels in the 
body, copper can either inhibit or enhance iron metabolism. A copper deficiency prevents 
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the release of iron. Hephaestin is a copper-dependent ferridoxase that helps to convert 
iron to the ferric state for transport by transferrin. Deficiencies in copper, and thus 
hephaestin, can lead to anemia as iron will remain in the ferrous state and consequently 
will be unable to be transported.32,18 Instead of being transported for red blood cell 
formation in the bone marrow, iron will accumulate in the liver, potentially resulting in 
hepatic iron overload. Fortunately, copper deficiency may take several years to develop 
due to being amply available in a variety of food sources, adequate storage in the liver, 
and very little daily excretion.31 However, the symptoms associated with copper 
deficiency can be severe and even irreversible, thus awareness and proper screening is 
essential for early diagnosis and treatment. 
 
Review of Nutritional Deficiencies after Bariatric Surgery 
After surgery, iron deficiency anemia occurs at a higher rate than in the general 
population, with studies showing the post-operative prevalence of anemia among RYGB 
patients ranging from 25-36% at 1 year and 34% at 3 years.13,33,34 In one particular study 
by Aarts et al, it was found that 71% of patients with anemia at 12 months after RYGB 
surgery were new occurrences.33 In another study by Skroubis et al, it was found that low 
levels of ferritin, a commonly used biomarker of anemia, increased from 6.5% prior to 
bariatric surgery to almost 56% 4 years post-operatively.35,36 
Although iron deficiency may be frequent following gastric surgery due to 
reduced absorption, bioavailability, and low dietary intake of iron, it does not account for 
all cases of anemia. Previously discussed micronutrient deficiencies, such as folate and 
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vitamin B12, are also common after bariatric surgery and contribute to anemia. Halverson 
et al.9 demonstrated that 33% of patients had vitamin B12 deficiency after bariatric 
surgery, with another study demonstrating that 22% of patients present with folate 
deficiency post-operatively.6 Other rates of deficiencies in folate, B12, and iron after 
surgery have been found to be 16%, 50%, and 70%, respectively.33 
Some cases of post-operative anemia may be a result of deficiencies that were 
present prior to surgery. While “over-nutrition” from energy-dense, nutrient poor foods is 
common in the obese patient, micronutrient deficiencies frequently co-exist. Kaidar-
Person et al.37 demonstrated that obese individuals, even in the absence of gastric surgery, 
are prone to deficiencies in thiamin, vitamin B12, folate, vitamin D, vitamin A, iron, and 
zinc, and preoperative anemia has been reported to be prevalent in 5-78% of patients.37,38 
Specifically, iron deficiency anemia has been reported in up to 44% of adults prior to 
bariatric surgery, which may further contribute to iron deficiency post-operatively.6 
Pre-operative anemia is of interest because it is associated with increased 
morbidity, longer impatient stays, and reduced survival following surgery.39,40 Side 
effects of anemia, whether prior to or after surgery, include fatigue, cold intolerance, 
insomnia, hair loss, tachycardia, shortness of breath when exercising, as well as reduced 
work capacity in adults and reduced visual and auditory functioning. 41,42 Many of these 
symptoms, such as shortness of breath and fatigue may even hinder the patient’s ability to 
exercise, further impacting their ability to sustain weight loss. As obesity and bariatric 
surgery rates climb, anemia will likely become an increasing concern.  
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Racial Disparities Pre and Post-Operatively 
Another increasingly apparent problem lies in the racial disparities that are seen 
after bariatric surgery. Despite significant health disparities associated with obesity 
across racial groups, there is surprisingly little research examining bariatric surgery 
outcomes between Blacks, Hispanics, and Caucasians. Much of the research examines 
weight loss outcomes or differences in co-morbidities, but there are very few studies that 
compare prevalence and risk of nutritional deficiencies across these three racial/ethnic 
groups before and after surgery.43 Results have mostly demonstrated differences in 
weight loss between Blacks and Caucasians after bariatric surgery, with Blacks having 
less weight loss than Caucasians.43,44,45 These post-operative weight loss differences may 
be due to differences in caloric intake, the nutrient composition of food intake, physical 
activity, socioeconomic status, and racial or ethnic differences in the acceptance of 
obesity.44-48 Moreover, biological mechanisms may play a role in post-operative weight 
loss.  
 There is some evidence that the pre-operative prevalence of anemia differs across 
these three racial/ethnic groups, which could affect post-operative biomarkers of anemia. 
For example, compared with Caucasians, Blacks have a higher pre-operative prevalence 
of anemia followed by Hispanics.49 Anemia has been found to be almost 3.5-fold more 
common in African-Americans than Caucasians, even after adjusting for demographic 
variables, socioeconomic factors, and comorbid conditions.47 African-Americans also 
have a higher prevalence of below-normal hemoglobin levels, with some studies pointing 
to an association with socioeconomic status, which differs by race.48,50-51 It is also 
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possible that the underlying causes of anemia simply vary by race due to inherited 
variants. For example, sickle cell anemia is more common in people of African descent 
and Hispanic-Americans. Perhaps differences are partially a result from gene mutations, 
or unknown adaptive mutations from environmental demands that contribute to racial 
variation.  
Nevertheless, there is limited knowledge regarding racial/ethnic differences in 
prevalence of nutrient deficiencies prior to and after bariatric surgery. While it is known 
that nutritional deficiencies do exist post-surgery, these deficiencies deserve a closer look 
considering the lack of evidence in the literature. To our knowledge, no one has explored 
the differences in clinical biomarkers of anemia among AA, HA, and CA individuals 
undergoing gastric bypass surgery. This study therefore, aims to examine the differences 
in levels of biomarkers of anemia following the RYGB procedure among these three 
racial/ethnic groups. Achieving the goals of this study will provide support for revising 
clinical recommendations and guidelines for supplementation as well as follow-up care, 
and will provide support for changes in treatment strategies for bariatric surgery, 
especially in high-risk racial groups.  
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Specific Aims and Objectives:  
The objective of the present study was to evaluate the effect of bariatric surgery, namely 
Roux-en-Y gastric bypass, on the levels of two micronutrients (ferritin and vitamin B12), 
as well as changes in HGB and HCT according to race/ethnicity among a population of 
subjects from Boston Medical Center. We carried out a retrospective cohort study using 
patient data collected from electronic medical records (EMR). Specifically, we aimed to 
observe and compare the following: 
1. Patterns of change in vitamin B12, ferritin, HCT, and HGB levels following 
Roux-en-Y gastric bypass surgery. 
2. Changes in these clinical biomarkers of anemia in three racial/ethnic groups: 
African-Americans, Hispanic-Americans, and Caucasian-Americans. 
We hypothesize that HCT, HGB, B12 and ferritin levels will persistently decrease over 
time after RYGB and these blood markers of anemia will occur beyond 4 years, despite 
supplementation. We also hypothesize that African-Americans or Hispanic-Americans 
will exhibit more exaggerated decreases in ferritin, HCT and HGB, compared to 
Caucasian-Americans, suggesting greater risk of anemia after RYGB in these groups. 
If African-Americans or Hispanic-Americans do experience lower blood levels of our 
selected biomarkers of anemia compared to Caucasians, this may be attributed to genetic, 
dietary, or other factors such as compliance with supplementation. We will test this 
hypothesis by focusing on the changes of these blood levels. The results of these analyses 
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will help establish better clinical guidelines for the management of patients after bariatric 
surgery.  
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METHODS 
Data were collected via a retrospective electronic medical record (EMR) review of 
individuals who underwent bariatric surgery at the Boston Medical Center (BMC) from 
2004 through 2015. The specific bariatric procedures these subjects underwent included 
the Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy, and adjustable gastric band 
(see Appendix for brief descriptions of procedures). All subjects were assessed pre-
operatively by a multidisciplinary team (bariatric surgeon, RD, psychologist), and the 
same clinical team provided follow-up care during the observation period of this study. 
Subjects excluded from the analyses included those who underwent surgical revisions 
and those who became pregnant. Of the remaining 1,513 adult bariatric patients, 1,046 
who had RYGB surgery were included. EMR data were examined to compare the change 
in biomarkers of anemia over time and to determine whether these changes were 
associated with race . 
Dietary Data  
Subjects were given diet instructions to follow at certain time periods after surgery. 
Subjects were first started on clear liquids 1-2 days after surgery (Stage 1), followed by a 
no- concentrated sweets , protein drink diet from day 2 up to 3 weeks after surgery (Stage 
2), then a protein soft foods diet starting 2-3 weeks after discharge and lasting 4-6 weeks 
(Stage 3). The final stage (Stage 4) consisted of a high-protein, low-fat, solid foods diet 
beginning roughly 6-8 weeks after surgery and continued indefinitely. During Stage 2, 
subjects were advised to begin taking their daily vitamin and mineral supplements. 
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Postoperative follow-up visits were scheduled with both the surgeon and the dietitian 
roughly 2 weeks after hospital discharge. Subjects were also scheduled to meet with a 
nutrition MD at 3 months and 9 months post-operatively.  
Clinical Data  
Data were extracted from patients’ EMRs by the BMC Clinical Data Warehouse. The 
records collected included patients’ demographic characteristics (age at surgery, gender, 
self-reported race, diagnosis of diabetes, type of bariatric procedure); pre-surgical BMI; 
baseline blood tests including HbA1c, hematocrit (HCT), hemoglobin (HGB), vitamin 
B12, and ferritin; and prior medical history for diagnoses of T2DM, hypertension, 
dyslipidemia, obstructive sleep apnea, and arthritis.  All diagnoses came from patient 
self-reported data.   
Statistical Analyses 
The main objectives of this study were to compare the changes in clinical biomarkers of 
RBC count over several years of follow up after RYGB surgery and to determine whether 
these changes differed by race. A low level of hemoglobin was defined by having an 
HGB level <12g/dl, a low hematocrit defined by having an HCT level < 35%, a low 
ferritin level defined by a level of  <30 μg/L, and a low vitamin B12 level < 200 ng/L. 
These values were chosen based on standard references lab values from Boston Medical 
Center. Data were collected over an 11 year period and analyzed using SPSS software, 
version 22. Time points were combined to ensure sufficient sample sizes and data at each 
time point. Six months to a year were combined into time point 1, <1yr-2 years was 
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combined into time point 2, >2-4 years was combined for time points 3, and years 4-11 
were combined into time point 4+.  
 We utilized mixed linear regression models to analyze the repeated measures of 
biomarkers over time in the three racial/ethnic groups. Comparisons among different 
races were also made by observing a fixed race x time interaction. We initially compared 
unadjusted means of HCT, HGB, ferritin, and B12 in each racial/ethnic group at baseline 
(pre-op), 6 months-1 year, >1-2 years, 2-4 years, and 4+years after RYGB and used an 
mixed model procedure. We then explored potential confounding of the racial/ethnic 
differences on our clinical biomarkers of interest by age at surgery, initial BMI, and sex.  
Baseline characteristics of the subjects were compared among racial/ethnic groups 
using analysis of variance (ANOVA) for continuous variables and chi-square testing for 
categorical variables. “Baseline” was defined as the visit closest to the surgery date. A 
value of 0.05 was considered statistically significant. 
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RESULTS  
Characteristics of all subjects are detailed in Table 1. The total sample size of 1,046 men 
and women included 286 AA (27.3%), 161 HA (15.4%), and 599 CA (57.3%) adults with 
a mean age of 45.4±11.0 years (all mean values are presented with standard deviation). 
The population was predominantly female, comprising 79.0%. The mean pre-operative 
BMI was 46.3±8.6 with the following subject reported comorbid conditions at baseline: 
46.5% with T2DM, 37.7% with hyperlipidemia, 31.5% with obstructive sleep apnea 
(OSA), and 68.3% with hypertension. Regarding bariatric procedures undergone by these 
patients, 76% of AA’s, 89% of HA’s, and 83% of CA’s had RYGB surgery. Other 
surgeries performed include the sleeve gastrectomy and the adjustable gastric band, with 
an average total of 8% having the sleeve gastrectomy, and 10.7% undergoing the 
adjustable gastric band surgery. Due to small numbers, however, in the sleeve 
gastrectomy and adjustable gastric band groups, results were obtained from our restricted 
patient population RYGB subjects only. 
  Compared to Hispanics, fewer African-Americans underwent bypass surgery 
(P<0.001). Caucasians had a higher percentage of hyperlipidemia (35.7%) compared with 
Hispanics (22.9%) and African-Americans (31.2%) (P=0.015); African-Americans had 
the highest prevalence of hypertension than both Hispanics and Caucasians (75.5%, 
58.6%, and 66.6%, respectively) (P<0.001), and the highest prevalence of low HbA1c 
(75.8%, 60.5%, and 58.5%, respectively) (P<0.001). African-Americans also had the 
highest prevalence of diabetes at 51.22% (p=0.040). Baseline BMI and presence of 
arthritis did not vary significantly between groups. These prevalence’s are detailed in 
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Table 1.  Baseline ferritin was about 30 mcg/L higher in CAs compared with HA’s 
(P=0.003) (Table 1). AA’s had a lower baseline HGB and HCT than both HA’s 
(P<0.001) and CA’s (P<0.001) (Table 1). On the contrary, AA’s had baseline B12 that 
were 66 ng/L higher than that of HA’s and 76 ng/L higher than that of CA’s 
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  Table 1: Characteristics of Included Subjects by Race at Baseline.  
   BMI=body mass index; HbA1c=glycated hemoglobin (values indicate abnormal),                  
   OSA=obstructive sleep apnea; HCT= Hematocrit; HGB=Hemoglobin.  
  Data are mean values ± standard deviation calculated using ANOVA 
   *All pairs were significant  
   a. Significant versus African-Americans 
 b. Significant versus Hispanic-Americans 
 c. Significant versus Caucasian-Americans 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
African 
Americans  
n=201 
Hispanic-
Americans 
n=106 
Caucasian- 
Americans 
N=344 
 
     Total 
    
  (p-values) 
Age, y (mean, s.d.) 
Sex (%) 
    Male 
    Female 
Initial BMI (kg/m2) 
Surgery Type (%) 
    Bypass 
Hyperlipidemia (%) 
OSA (%) 
Hypertension (%) 
Arthritis (%) 
Diabetes (%) 
HbA1c (%) 
HCT (%)  
HGB, g/dL  
Serum Ferritin,  
μg/L 
B12, ng/L 
    46.4±10b 
 
    10.6%b,c 
    89.4%b,c 
    45.9±7.5 
   
   76%b,c 
   31.2% 
   26.7% 
   75.5%b,c  
   11.6% 
   51.2%   
   75.8%b,c 
   38.2±4.7 
   12.6±1.8 
   84.1±109.8c 
   
 559.9±276.7b,c        
  41.6±10a,c 
 
   19.1%a  
   80.9%a 
  44.6 ± 8.3 
   
  89%a 
  22.9%c  
  30%c  
  58.6%a 
  10.8%  
  43.3%c 
  60.5%a  
  39.2 ± 4.4 
  13.0± 1.6 
  81.5 ±93.1c 
   
494±229.5a        
 45.9±11.5b 
 
   26.1%a 
   73.9%a 
   45.5±8.1 
   
    83%a 
   35.7%b 
   33.3%b 
   66.6%a 
   8.5% 
  45.2%b 
  58.5%a 
  40.6±4.8 
  13.6±1.5 
111.7±109a,b 
 
483.8±201a 
45.4±11 
 
33% 
67% 
46.3±8.6 
 
82% 
37.7% 
31.5% 
68.3% 
10% 
46.5% 
65% 
39.7±4.8 
13.2±1.7 
79.3±105 
 
508±232.8        
  <0.001 
  
 <0.001 
 <0.001 
   0.278 
    
 <0.001 
   0.015 
 <0.05 
   0.001 
   0.387 
   0.040 
 <0.001 
 <0.001* 
 <0.001* 
   0.003 
 
  <0.01 
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Table 2. Numbers of Subjects Attending Follow-up Visits, according to Race/Ethnicity 
 
 
Gastric Bypass 
  n 
African American Baseline 201 
N= 286 6 mo-1 year 227 
 1-2 years 
2-4 years  
4+ years                 
155 
144 
86 
   
   
Hispanic-American Baseline 106 
N=161 6 mo-1 year 134 
 1-2 years 
2-4 years 
78 
73 
 4+ years 41 
   
   
Caucasian-American Baseline 344 
N=599 6 mo-1 year 452 
 1-2 years 
2-4 years 
241 
168 
 4+ years 115 
   
   
Total N= 1,046   
*n=number of subjects at each follow-up time period 
 
 
Table 3. Range of Follow-up Time for Each Visit After Surgery 
Time  Days Since Surgery 
1 (6mo-1 year) 182.5-365 
2 (1-2yr) 366-731 
3 (2-4 yrs) 732-1461 
4 (4+ years) 1462-2555 
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HCT Analyses:  
As illustrated in Figure 2A, all racial/ethnic groups experienced a decline in mean 
HCT. Post hoc analyses demonstrated that AA’s had significantly lower HCT levels 
compared with CA’s at significant baseline (p<0.001) and at time point 3 (2-4 years post-
surgery) (p<0.004). The mean HCT at these time points in AA’s was 38.2±4.7 and 
33.6±5.4, respectively, and 40.6±4.8 and 36±5.4, respectively in CA’s (Table 4). HA’s 
also had significantly lower HCT levels compared with CA’s at time point 1 (p=0.001). 
There were no significant differences between AA’s and HA’s throughout the 
observation period. All subjects in the three racial/ethnic groups showed decreases in 
HCT levels over time up to time point 2 after RYGB. From time point 2 to the end of the 
observation period, levels appear to plateau, yet HCT levels for AA’s remained 
consistently lower than both HA and CA subjects. 
Interestingly, Caucasian-Americans experience the greatest drop in HCT over 
time, with a total decline of 4.7% over the observation period compared to 4.5% g/dL for 
HA’s and 3.4% for AA’s (Table 4). Nonetheless, HCT levels in CA’s remained higher 
than AA’s and HA’s throughout most of the observation period.     
Furthermore, mixed model analyses showed an overall effect of race and time on 
changes in HCT level, with all groups experiencing a significant decrease in HCT 
(p<0.001) within the first 6 months-1 year (time point 1) following surgery.  
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 Figure 2. Changes in mean HCT % over time in all patients by race. Time points represent the following 
time ranges: 0= before surgery; Time points represent the following time ranges: 0= before surgery; 1=6 
month-1 year; 2=>1-2 years; 3=>2-4years; 4= 4+ years. (B) Mean values adjusted for fixed effects of initial 
BMI. 
                                                                                                                                   
Incorporating covariates into the mixed model, only initial BMI was a significant factor 
that influenced the effects of race on HCT over time (Figure 2B). The effects were very 
small, however, with every 1 unit increase in BMI causing a decrease in HCT by 0.017%. 
After adjustment for thos covariate, all previously observed significant differences 
remained with CA’s continuing to have greater HCT levels than AA’s and HA’s. The 
adjusted means of HCT over time, accounting for initial BMI is shown in Figure 2B. 
 
HGB Analyses: 
  Differences in HGB levels after surgery between racial/ethnic groups are detailed 
in Figure 3. Post hoc analyses demonstrated significant racial/ethnic differences between 
CA’s and AA’s at baseline (p<0.001), at time point 3 (2-4 years post-surgery) (p<0.001), 
and at time point 4 (p=0.018), with CA’s exhibiting higher mean HGB levels.. CA’s also 
had significantly higher HGB levels compared with HA’s at baseline (P=0.047). CA’s 
have a mean HGB level of 13.6±1.5 at baseline compared with 12.6±1.8 for AA’s, and 
13±1.6 for HA’s (Table 4).  However, Caucasian-Americans experienced the greatest 
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drop in HGB over time, with a total decline of 1.87 g/dL over the observation period 
compared to 1.48 g/dL for HA’s and 1.41 g/dL for AA’s (Table 4). Nonetheless, HGB 
levels decreased across all racial/ethnic groups over the observation period with AA’s 
beginning with the lowest mean HGB of 12.56 g/dL and continueing to have the lowest 
HGB level (Table 4). 
Using mixed model analyses, there was an overall effect of race and time on changes in 
HGB level for the sample population (p<0.001), and the the fixed effect of the race x time 
interaction revealed significant changes (p<0.001). Immediately following bariatric 
surgery, all groups experienced a significant decline in HGB levels, with a mean decrease 
in HGB of 1 g/dL (P<0.001) at time point 1 (Figure 3A). Throughout the entire 
observation period,  there was a significant average decrease across the three racial/ethnic 
groups, beginning with a mean HGB of 13.06±0.05 at baseline to 11.55±0.05 at 4 years 
(p<0.001).  
A.             B.  
 
 
 
Figure 3. (A) Changes in mean HGB over time in all patients by race. Time points represent the following 
time ranges: 0= before surgery; Time points represent the following time ranges: 0= before surgery; 1=6 
month-1 year; 2=>1-2 years; 3=>2-4years; 4= 4+ years. (B) Mean values adjusted for fixed effects of age, 
initial BMI, and sex.  
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Incorporating covariates into the mixed model, age at surgery, initial BMI, and sex were 
all significant factors that influenced the effects of race on HGB over time. After 
controlling for these three factors, the mixed model fixed effects of race, time, and race x 
time on HGB level all remained significant (p<0.001). The estimated baseline HGB for 
CA’s also remained higher than AA’s (p<0.001) and HA’s (p<0.003). The adjusted 
means of HGB over time, accounting for these three factors are shown in Figure 3B and 
Table 5. 
Ferritin Analyses   
          As shown in Figure 4, mean ferritin levels decreased over time for all racial/ethnic 
groups.  CA’s showed the greatest decrease in ferritin after RYGB, while AA’s showed 
the smallest decrease. From baseline to 4+ years, mean ferritin levels decreased by 27.8 
ng/L for AA’s, 50.59 ng/L for HA’s, and 54.47 ng/L for CA’s (Table 4). There were no 
significant racial/ethnic differences, however, at any time point throughout the 
observation period, expect for at baseline between AA’s and CA’s (p=0.028). After 
adjusting for covariates in Figure 4B, mean ferritin levels for AA’s were significantly 
higher than CA’s (p=0.008) at time point 3.  
          The mixed model fixed effects of race, time, and analyses of the race x time 
interaction all showed significant effects on mean ferritin levels. After an initial increase 
at time point 1 for AA’s and HA’s, all racial/ethnic groups experienced a significant 
decline in ferritin levels immediately after that, at time point 2, as shown in Figure 4A 
(p=0.044). The effect of surgery over time continued to have a significant effect on mean 
ferritin levels at every time point throughout the observation period (p=0.01) except for 
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between time points 3 and 4 (p=0.213).  
 
 
Incorporating covariates into the mixed model, age at surgery, initial BMI, and sex were 
all significant factors that influenced the effects of race on ferritin level over time.. After 
controlling for these three factors, the mixed model fixed effects of time and the race x 
time interaction remained significant (p<0.001 and p=0.009 respectively); however the 
effect of race was no longer significant (p=0.433). The adjusted means of ferritin over 
time, accounting for these three factors are shown in Table 5. 
 
B12 Analyses 
There were notable changes in B12 levels over the observation period after surgery, 
though mean B12 levels never reached a level of deficiency, defined as < 200 ng/L, in 
any racial/ethnic group (Figure 5). Deficiencies in mean B12 were still observed, 
however, over the observation period, though these numbers were quite small. For 
A.
 
B.
 
Figure 4. (A) Changes in mean Ferritin over time in all patients by race. Time points represent the 
following time ranges: 0= before surgery; Time points represent the following time ranges: 0= before 
surgery; 1=6 month-1 year; 2=>1-2 years; 3=>2-4years; 4= 4+ years. (B) Mean values adjusted for fixed 
effects of age, initial BMI, and sex. 
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example, at baseline, 1 AA was measured as having a mean B12 level indicative of 
deficiency, compared to 2 HA’s, and 7 CA’s. At the end of the observation period, the 
number of people with deficient B12 levels increased to 8 for AA’s, 5 for HA’s, and 
decreased to 6 for CA’s.  
As shown in Figure 5A, at baseline, mean B12 levels were higher in AA’s than 
both HA’s and CA’s (559.9±276.7, 494.02 ±229.5, and 483.8±200.9, respectively), as 
well as throughout the entire observation period (Table 4). At the end of the observation 
period, levels in AA’s, HA’s, and CA’s were 704.5±532.2, 564.4±453.7, and 
665.96±512.3, respectively (p=0.088). Post hoc analyses demonstrated significant 
racial/ethnic differences between CA’s and AA’s at time point 1 (6months-1 year after 
surgery) (p=0.028) and at time point 3 (2-4 years post-surgery) (p=0.050). The difference 
in mean B12 between these two groups was 142.4 ng/L and 148.3 ng/L at time points 1 
and 3, respectively. There were also significant differences at these time points between 
AA’s and HA’s with a mean difference of 121.3 ng/L at time point 1 (p=0.003) and a 
difference of 123.4 ng/L at time point 3 (p=0.042). Significant differences were observed 
between CA’s and HA’s at time point 1 as well. The mean B12 difference between CA’s 
and HA’s at time point 1 was 21.1 ng/L (p=0.047). All differences are detailed in Table 4. 
The mixed model analyses showed significant effects of race and time, but the 
race x time interaction on mean B12 was not significant in the overall patient population 
(p= 0.192). The significant effects of surgery over time across all racial/ethnic groups can 
be seen in Figure 5A. There was a significant average increase in mean B12 levels by 209 
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ng/L from baseline to time 1 post-surgery (p<0.001) and significant average increase of 
132.4 ng/L from baseline to time 4 across all racial/ethnic groups (P<0.001). 
 
A. B.  
Figure 5. (A) Changes in mean B12 over time in all patients by race. Time points represent the 
following time ranges: 0= before surgery; Time points represent the following time ranges: 0= before 
surgery; 1=6 month-1 year; 2=>1-2 years; 3=>2-4years; 4= 4+ years. (B) Mean values adjusted for fixed 
effects of age and initial BMI. 
After assessing for the confounding effects of sex, age, and pre- BMI, only initial BMI 
and age were found to significantly confound our results. The adjusted means of B12 
over time, accounting for these two factors are shown in Figure 5B. After controlling for 
these factors, the mixed model fixed effects of race and time on B12 level remained 
significant (p<0.001) and the race x time interaction remained nonsignificant (p=0.192). 
Furthermore, when these two factors were added to the model there was no longer a 
significant difference between AA’s and HA’s at time point 3 (p=0.087). 
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        Time          AA     HA       CA   p-value 
Unadjusted mean± s.d. 
 
Data are mean values ± standard deviation calculated using ANOVA 
 
  
 
Hematocrit (%) 
  
Baseline 38.2±4.7 39.2±4.4         40.6±4.8                <0.001 
0.5 - 1 yr 34.6±5.3 35.9±5.2 35.6±5.6 <0.001 
>1-2 yrs 34.8±5.3 34.9±6.4 36.1±5.8 <0.001 
>2-4yrs 33.6±5.4 34.5±6.1 36.0±5.4 <0.001 
>4yrs 34.5±5.8 34.6±6.0 35.8±5.7 <0.001 
  
 Hemoglobin 
(g/dL) 
 
 
Baseline 12.6±1.8 13.0±1.6 13.6±1.5 <0.001 
        0.5 - 1 yr 11.5±1.8 12.1±1.7 12.2±1.8 <0.001 
>1-2 yrs 11.5±1.8 11.8±2.2 12.2±1.9 <0.001 
>2-4yrs 11.0±1.8 11.6±2 12.1±1.9 <0.001 
>4yrs 11.2±1.98 11.5±1.9 11.8±2.0 <0.001 
  
 Serum Ferritin 
(μg/L) 
 
 
Baseline  84.1±109.8 81.5±93.1 111.7±109.0 0.001 
0.5 - 1 yr 89.9±109.4 83.5±106.2 98.8±96.4 0.098 
>1-2 yrs 67.4±131.5 73.6±172.4 74.4±99.0 0.801 
>2-4yrs  69.0±124.0 45.6±94.2 54.5±81.3 0.080 
>4yrs   56.3±73.0 31.9±37.5 57.2±71.0 0.004 
  
  
Vitamin B12 
(ng/L) 
 
 
Baseline 559.9±276.7 494.0±229.5   483.8±200.9      <0.001 
0.5 - 1 yr 810.2±559.7 688.9±489.7 667.8±449.9           <0.001 
>1-2 yrs 770.7±582.7 593.7±426.5 638.6±443.6 0.001 
>2-4yrs 765.5±565.3 642.1±494.7 617.2±449.1 0.003 
>4yrs 704.5±532.2 564.4±453.7 665.9±512.3 0.088 
 
Table 4. Mean Levels of Biomarkers of Anemia Following Gastric Bypass Surgery 
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Table 5. Mean Levels of Biomarkers of Anemia Following Gastric Bypass Surgery 
Adjusted for Covariates 
 
  
    Time               AA                HA       CA       p-value 
  Adjusted mean ± s.d.   
  Adjusted for baseline age, sex, BMI   
  Hematocrit (%) 
Baseline      38.2 ±4.7 39.1±4.4 40.6±4.8 <0.001 
0.5 - 1 yr          34.9±5.2 35.9±5.3 35.6±5.6 <0.001 
>1-2 yrs          35.1±5.4 34.8±6.5 36.3±5.6 0.001 
>2-4yrs         33.6±5.5 34.9±6.1 36.0±5.5 <0.001 
>4yrs        35.0±5.9 34.6±6.0 35.9±5.6 0.007 
     Hemoglobin (g/dL) 
Baseline 12.6±1.8   12.9±1.6 13.6±1.7 <0.001 
0.5 - 1 yr 11.7±1.8 12.1±1.7 12.2±1.8 <0.001 
>1-2 yrs 11.5±1.9 11.8±2.2 12.2±.02 <0.001 
>2-4yrs 11.1±1.8 11.7±2.1 12.1±1.9        <0.001 
>4yrs 11.3±2.0 11.5±1.9 11.8±1.9 <0.001 
     Serum Ferritin (μg/L) 
Baseline  86.4±109.7 85.9±93.7 105.1±109.0 0.103 
0.5 - 1 yr 92.4±109.4 89.5±107.6 89.8±96.4 0.897 
>1-2 yrs 72.1±131.5 85.2±175.9 64.3±99.0 0.367 
>2-4yrs  72.5±124.9 59.5±94.2 45.9±81.3 0.028 
>4yrs   61.1±73.0 52.6±37.5 55.8±71.0  0.391 
  Vitamin B12 (ng/L) 
Baseline 560.3±278.6 493.6±231.1 483.0±201.4 <0.001 
0.5 - 1 yr 817.5±563.8 698.1±494.0 669.2±452.7 <0.001 
>1-2 yrs 789.3±586.9 605.2±432.2 645.9±450.7 <0.001 
>2-4yrs 779.2±575.2 656.7±500.2 613.9±451.3 <0.001 
>4yrs 701.7±528.0 574.4±457.6 668.6±513.8 0.156 
 
 
   
Data are mean values ± standard deviation calculated using ANOVA 
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DISCUSSION 
Anemia, resulting from nutrient deficiencies, following bariatric surgery occurs at a 
frequency between 20-60%. 8, 52-53 Though several studies report a substantial 
prevalence of deficiencies in patients prior to bariatric surgery, the effects of surgery 
account for the deficiencies seen after surgery as well.52, 54-55 Due to the malabsorptive 
nature of RYGB surgery, these patients are particularly prone to developing 
deficiencies of iron, folate, and B12 after surgery.56 
Additionally, racial/ethnic differences in the development of deficiencies after 
surgery remain poorly studied. Therefore, the primary aim of this study was to compare 
the effects of bariatric surgery on micronutrient blood levels of HCT, HGB, ferritin and 
B12 across three different racial/ethnic groups over time. This study showed that mean 
levels of biomarkers of anemia decrease over time, among the entire sample, most 
notably for ferritin. There were significant decreases within 6 months- 1 year (time 
point 1) following surgery among the entire sample for HCT and HGB. There were 
differences in mean levels of these biomarkers between races, with ethnic minorities 
exhibiting lower levels of HCT and HGB throughout our study. Specifically, Hispanic-
Americans had the lowest biomarker levels at the end of the observation period for 
HCT, Ferritin, and B12. Conversely, AA’s and HA’s had higher levels of mean B12 
before and after RYGB compared to CA’s. Finally, it appeared that CA’s had the 
greatest total decline in HCT and ferritin over time. 
These racial/ethnic disparities in post-surgical nutritional outcomes might be 
related to a variety of factors. We found that at baseline, AA’s had the lowest HGB and 
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HCT levels, which may explain their continued lower levels compared to CA’s and 
HA’s throughout most of the observation period. We also found that level of deficiency 
pre-operatively for HA’s was predictive of deficiency post-operatively, as HA’s had the 
lowest levels of ferritin at baseline as well as after-surgery. Poor availability of nutrient 
rich healthy foods in areas where minority populations are concentrated may explain 
why we see the lowest blood levels in HA’s and AA’s.57 On the contrary, AA’s had the 
highest B12 levels throughout the observation period. In prior studies, AA’s have been 
found to have a higher level of B12 compared to CA’s, though the reason for this 
difference remains unclear. 58 It has been suggested that race-ethnic differences in 
serum vitamin B-12 reflect genetic differences, environmental factors, or both. 59,60 
Nonetheless, further studies are warranted to assess and better understand how patient 
characteristics determine success and nutritional outcomes after bariatric surgery. 
One of our other objectives was to test the hypothesis that ferritin, B12, HGB, and 
HCT persistently decrease over time after RYGB. Thus, our study allowed us to 
observe the specific effects of race over a longer observation period. This was essential 
in order to see when the lowest levels occur for each of these biomarkers of anemia. 
The lowest levels observed, after averaging the groups, occurred at time point 3 (2-4 
years after surgery) for HCT, and time point 4 for B12, ferritin, and HGB. While this 
could be due to the most sick patients returning for follow-up visits, it nonetheless 
shows that low levels of these biomarkers of anemia prevail in patients over an 
extended period of time. These findings are consistent with previous reports of 
nutritional deficiencies after bariatric surgery, where incidences of deficiencies occur as 
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early as 1 year after surgery and extend beyond 3 years.4 Our findings also agree with 
Skroubis et al, who observed nutrient deficiencies related to anemia at 4 years post-
RYGB surgery.35 However, other studies have shown that B12 deficiency occurs at a 
rate of 30-40% at 4 years post-surgery, whereas in our study,  mean B12 levels never 
reached a level of deficiency. Studies have also investigated the appropriate dosing of 
vitamin B12 supplements following surgery, and in one study a dose of at least 350 
micrograms was needed to maintain adequate B12 levels. All of our subjects were 
instructed to take a B12 complex containing much more than that at 500-1200 
micrograms daily.11 
Within our total population, the percentage of patients with below normal levels 
of our studied biomarkers of anemia rose across all three racial/ethnic groups within the 
first year following surgery. There was a notable recovery and slow increase towards 
baseline levels for HCT and HGB, whereas ferritin continued to sharply decline over 
the observation period. One potential mechanism for ameliorating levels over time is 
supplementation. Patients are advised to take supplements containing 18 mg of Iron 
twice daily as well as a B complex containing anywhere from 500-1200 mcg. However, 
if patients become deficient, they are repleted when they return for a follow-up 
appointment.  
Strengths and Limitations 
A major strength of this study is the large size and ethnic diversity of the study 
population, which allowed us to compare three major racial/ethnic groups. This is one of 
the first studies to compare nutritional deficiencies across three diverse populations after 
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RYGB surgery. Most studies focus on weight loss outcomes only in AA’s versus 
CA’s.45,46 Another strength is that longitudinal mixed modeling was used to allow for the 
control of both “fixed” and “changing” covariates, and by utilizing these multivariable 
models, we were able to effectively assess the effect of race on clinical biomarkers of 
anemia over time. Also, a longer period of observation allowed us to follow subjects over 
a longer period of time, beyond the usual 3-4 years.4 Our study is one of the first focusing 
on time of onset of post- operative deficiencies of anemia and following patients over an 
extended period of time. Only a few other studies have shown continuous declines in 
nutritional status, with few related to anemia, after 6 years of surgery.13 Lastly, another 
strength of the study is that all subjects received the same surgery at Boston Medical 
Center and were followed by the same surgical and medical teams, thereby reducing any 
bias caused in the type of clinical management and care received.  
There are also several limitations as well. First, this retrospective study may have 
some bias and confounding, as the patients who returned for follow-up are the ones 
whose lab values and data is available. There are missing data values as not all patients 
returned for every exam, some returned more than others, and there are missing baseline 
lab values. This was seen for all biomarkers of anemia, but especially for those that had 
the sleeve gastrectomy for vitamin B12, HCT, HGB, and ferritin. At some time points, 
we had zero lab values for any of these patients. Due to the exceptionally small numbers 
for this type of surgery at some of the time periods, we restricted our analyses to bypass 
surgery subjects only, which consisted of 1,046 subjects compared to 121 sleeve 
gastrectomy subjects. Sample size also varied substantially between the 3 races with 
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CA’s comprising over half of the entire patient population (286 AA (27.3%), 161 HA 
(15.4%), and 599 CA (57.3%)), which may have affected results as more data was 
available for CA’s.  
Furthermore, supplementation practices by subjects were not provided and 
included in the analysis. Therefore, adherence, or lack thereof could be a potential 
confounder to our findings. Non-compliance with supplements is unfortunately quite 
common.4 It has been shown that patients advised to take multivitamins often comply 
1-5 months post-operatively, but only 55% are still taking the supplements at 12 
months.61  
Other limitations include that this was a retrospective rather than controlled 
prospective study and we did have substantial loss to follow-up. Second, the study relied 
entirely on clinical data from EMRs. Both of these limitations meant that time points at 
which data were available varied in frequency and the total amount of lab values 
collected differed between vitamin B12, ferritin, HCT, and HGB. Since this study is non-
randomized and based on retrospective data, baseline factors such as age, sex and initial 
BMI distribution were different in each ethnic group. While we were able to control for 
these factors, we lacked data and did not control for a number of other potentially 
important confounding factors such as socioeconomic status, physical activity levels, type 
of supplement provided and length of time taken by patients, behavioral differences, and 
dietary factors. 
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CONCLUSION 
Despite limitations, this study offers unique insight into the relationship between 
race and nutritional deficiencies related to bariatric surgery. This study found that 
racial/ethnic differences occur between different biomarkers of anemia after weight loss 
surgery, with ethnic minorities exhibiting the lowest levels for a majority of the 
biomarkers over an extended period of time. This study suggests a risk of anemia after 
RYGB in these groups. Thus, it is critical to consider race/ethnicity when providing 
treatment for patients undergoing gastric bypass surgery. Better understanding and 
awareness of these disparities may allow for identification and targeting of these specific 
patients who are at higher risk of anemia as well as help guide healthcare professionals in 
decision making about long-term treatment options for these patients. 
Furthermore, this study’s results provide preliminary support for future studies 
investigating the potential primary role of bariatric surgery and race on nutritional 
outcomes related to anemia. Of particular importance is the fact that obesity and bariatric 
surgery rates will likely continue to climb as will anemia. It’s important to prevent this 
from becoming an ever-increasing concern. It’s evident that patients who have had 
bariatric surgery require lifelong follow-up of hematological markers of anemia since 
anemia may develop and persist years after surgery
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APPENDIX 
Roux-en-Y gastric bypass (RYGB), adjustable gastric banding (GB), and the sleeve 
gastrectomy (SG) (Figure 6). In RYGB, a small gastric pouch is constructed by stapling 
the stomach. This is then attached to the jejunum, a distal portion of the small intestine. 
Thus, the lower portion of the stomach and the duodenum are bypassed by food. 
Complications include malabsorption. In the Lap-band, a saline-filled band is wrapped 
around the upper portion of the stomach to restrict food from passing into the rest of the 
gastrointestinal tract. The size of the opening that controls entry of food into the stomach 
is controlled by injection or withdrawal of fluid in the band. Complications include band 
slippage or rupture, nausea, vomiting, and stricture formation in the stomach. In SG, it is 
a purely restrictive procedure in which the size of the stomach is greatly reduced, leaving 
a sleeve shaped stomach, so that one feels full sooner. Complications include nausea and 
vomiting. 
 
 
 
 
 
 
 
Figure 6: The three most commonly performed bariatric procedures. (A) Roux-en-Y gastric 
bypass (RYGB); (B) Gastric band (GB); (C) Sleeve gastrectomy (SG). Taken from Neff and le 
Roux62
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